针对肿瘤的抗体药物偶联物:加速批准

{"title":"针对肿瘤的抗体药物偶联物:加速批准","authors":"Stuart Jamieson, Daniel P Myatt, J. Liddell","doi":"10.18609/ioi.2021.042","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibody drug conjugates: accelerated approvals targeting oncology\",\"authors\":\"Stuart Jamieson, Daniel P Myatt, J. Liddell\",\"doi\":\"10.18609/ioi.2021.042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73351,\"journal\":{\"name\":\"Immuno-oncology insights\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-oncology insights\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18609/ioi.2021.042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18609/ioi.2021.042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}